Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Chart

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) for XWEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Annual Per Share) Benchmarks
Start Trial
FONAR Corp. Upgrade
ProPhase Labs, Inc. Upgrade
Veracyte, Inc. Upgrade
Insight Molecular Diagnostics, Inc. Upgrade
Exagen, Inc. Upgrade